[Cell based therapy for articular cartilage injury].

Area of Science:

• Orthopedics and Regenerative Medicine
• Biomaterials Science

Background:

• Articular cartilage exhibits poor intrinsic regeneration capacity, making cartilage injuries prone to developing into osteoarthritis.
• Current treatments like autologous chondrocyte implantation (ACI) show promise but face limitations.

Purpose of the Study:

• To address the limitations of ACI, specifically the restricted chondrocyte yield and the need for invasive arthrotomy.
• To explore alternative cell sources and less invasive delivery systems for enhanced articular cartilage repair.

Main Methods:

• Investigating the potential of mesenchymal stem cells (MSCs) as an alternative cell source for cartilage regeneration.
• Developing and evaluating novel, less invasive cell delivery systems for tissue-engineered cartilage implantation.

Main Results:

• ACI using three-dimensional culture in atelocollagen gel has demonstrated positive clinical outcomes for articular cartilage injuries.
• Limitations of ACI include a finite number of harvestable chondrocytes and the requirement for arthrotomy.

Conclusions:

• Improving cell-based articular cartilage treatment necessitates exploring alternative cell sources like MSCs.
• Developing less invasive and more efficient cell delivery systems is crucial for advancing clinical applications in cartilage repair.
• Translational research plays an increasingly vital role in the clinical application of articular cartilage repair strategies.